← Back to headlines
Novo Nordisk's Pricing Strategy Could Expand Obesity Market
Novo Nordisk's recent shift in pricing strategy for its obesity treatments is analyzed as a potential catalyst to unlock and significantly expand the overall market for obesity medications.
3 Apr, 21:22 — 3 Apr, 21:22
Sources
Showing 1 of 1 sources
